A detailed history of Ethic Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Ethic Inc. holds 12,095 shares of TECH stock, worth $817,259. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,095
Previous 12,920 6.39%
Holding current value
$817,259
Previous $925,000 4.43%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$70.96 - $82.35 $58,541 - $67,938
-825 Reduced 6.39%
12,095 $966,000
Q2 2024

Aug 13, 2024

BUY
$62.12 - $84.15 $51,249 - $69,423
825 Added 6.82%
12,920 $925,000
Q1 2024

May 13, 2024

BUY
$65.98 - $77.09 $49,221 - $57,509
746 Added 6.57%
12,095 $851,000
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $137,410 - $203,450
2,601 Added 29.73%
11,349 $875,000
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $92,299 - $122,237
-1,367 Reduced 13.51%
8,748 $595,000
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $58,491 - $68,182
-793 Reduced 7.27%
10,115 $825,000
Q1 2023

May 12, 2023

SELL
$71.62 - $86.62 $341,484 - $413,004
-4,768 Reduced 30.42%
10,908 $809,000
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $989,175 - $4.32 Million
12,262 Added 359.17%
15,676 $1.3 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $246,092 - $341,301
871 Added 34.25%
3,414 $970,000
Q2 2022

Aug 10, 2022

BUY
$322.67 - $449.65 $63,888 - $89,030
198 Added 8.44%
2,543 $882,000
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $200,632 - $276,576
567 Added 31.89%
2,345 $1.02 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $258,637 - $297,709
567 Added 46.82%
1,778 $920,000
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $129,902 - $157,352
292 Added 31.77%
1,211 $587,000
Q2 2021

Aug 10, 2021

BUY
$387.35 - $450.26 $139,833 - $162,543
361 Added 64.7%
919 $414,000
Q1 2021

May 13, 2021

BUY
$314.62 - $411.0 $175,557 - $229,338
558 New
558 $213,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.65B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.